Febuxostat 40/80mg

Febuxostat 40/80mg
Product Description

Febuxostat Tablets 40 mg and 80 mg are oral, film-coated tablets containing febuxostat, a potent and selective xanthine oxidase inhibitor indicated for the chronic management of hyperuricemia in patients with gout. By selectively inhibiting xanthine oxidase, febuxostat reduces the production of uric acid, thereby lowering serum urate concentrations and promoting the dissolution of monosodium urate crystals. This helps prevent recurrent gout flares, reduces tophi formation, and minimizes long-term joint damage associated with chronic hyperuricemia. Febuxostat is highly selective for xanthine oxidase and has minimal effects on other enzymes involved in purine and pyrimidine metabolism. The tablets are intended for once-daily oral administration, with or without food, and should be used under the supervision of a qualified healthcare professional. Manufactured in accordance with current Good Manufacturing Practices (cGMP).

Read more Show less

Swiftmed International Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2026
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    Febuxostat Tablets 40 mg and 80 mg are supplied as film-coated tablets for oral administration, each containing 40 mg or 80 mg of febuxostat as the active pharmaceutical ingredient. The product belongs to the xanthine oxidase inhibitor therapeutic class and is indicated for the long-term treatment of hyperuricemia associated with gout. The tablets are film-coated, with the appearance varying according to the approved formulation and strength, and are packaged in Alu-Alu or PVC/Aluminium blister packs or HDPE bottles, depending on market requirements. The product should be stored below 30°C in a dry place, protected from moisture and light, and kept out of the reach of children.
More specifications Fewer specifications

Swiftmed International Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2026
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile

More Products from Swiftmed International Private Limited (99)

  • Empty Disposable Injection Pen Medical Device

    Product Empty Disposable Injection Pen Medical Device

    Our Disposable Injection Pen (Outward Rotation Type) is a multi-dose drug delivery device designed for accurate, convenient, and reliable subcutaneous administration. Featuring an outward-rotation dosing mechanism, it provides intuitive dose setting and smooth operation.

    Specifications: Dose ran...
  • Empty Disposable Single Dose Injection Pen (Autoinjector)- Medical Device

    Product Empty Disposable Single Dose Injection Pen (Autoinjector)- Medical Device

    Manufactured by Swiftmed Medical Devices Private Limited, our Disposable Autoinjector Pen is a single-dose drug delivery device designed for simple, reliable, and convenient subcutaneous administration. The autoinjector supports a dose range of 20–200 IU (200–2,000 μL) with an accuracy of ±5%.

    S...
  • Empty Reusable Injection Pen- Medical Device

    Product Empty Reusable Injection Pen- Medical Device

    Swiftmed Medical Devices Private Limited offers a high-quality Reusable Multi-Dose Pen designed for accurate, convenient and reliable administration of injectable medicines. Engineered in accordance with ISO 11608 standards, the pen provides a dose range of 1–80 IU (10–800 μL) with dosing accuracy complian...
  • Enoxaparin Sodium Injection PFS USP

    Product Enoxaparin Sodium Injection PFS USP

    Enoxaparin Sodium Injection is a prescription low-molecular-weight heparin (LMWH) anticoagulant. It is used for the immediate prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and acute coronary syndromes (heart attacks)
  • Ertapenem

    Product Ertapenem

    Ertapenem 1 g injection is a broad-spectrum carbapenem antibiotic used to treat moderate-to-severe bacterial infections. Unlike other carbapenems (like meropenem), ertapenem is unique because it features a prolonged half-life, allowing for convenient once-daily dosing in adults. It is highly stable against...
  • Ertugliflozin

    Product Ertugliflozin

    Ertugliflozin is a prescription medication used to manage type 2 diabetes. It belongs to the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors.
  • Ferrous Carboxymaltose Injection

    Product Ferrous Carboxymaltose Injection

    Ferric carboxymaltose injection is an intravenous iron replacement therapy used to rapidly treat iron deficiency anemia (IDA). It is an iron carbohydrate complex designed to release controlled elemental iron directly into the bloodstream, bypassing gastrointestinal absorption.
  • Fluconazole

    Product Fluconazole

    Fluconazole is a prescription triazole antifungal medication used to treat and prevent a wide range of superficial and systemic fungal infections. It is a highly reliable, systemic agent that functions by shutting down the synthesis of essential fungal cell membrane components
  • Fluticasone Propionate 50 mcg + Azelastine 140 mcg Nasal Spray

    Product Fluticasone Propionate 50 mcg + Azelastine 140 mcg Nasal Spray

    Fluticasone Propionate 50 mcg + Azelastine Hydrochloride 140 mcg Nasal Spray is a fixed-dose combination intranasal formulation indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis in adults and adolescents. The product combines the anti-inflammatory properties of Fluticasone...
  • Gliclazide 30/60/80mg MR + Metformin 500mg ER

    Product Gliclazide 30/60/80mg MR + Metformin 500mg ER

    Gliclazide combined with metformin hydrochloride is a prescription fixed-dose oral antidiabetic medication used to optimize blood sugar control in adults with type 2 diabetes mellitus. It pairs a pancreatic insulin secretagogue with a hepatic insulin sensitizer to manage both fasting and post-meal glucose ...
  • Glimepiride and Metformin Extended-Release (XR)

    Product Glimepiride and Metformin Extended-Release (XR)

    Glimepiride and Metformin Extended-Release (XR) tablets are a combination oral blood sugar-lowering medication used to manage Type 2 Diabetes. It combines a sulfonylurea, which prompts the pancreas to release more insulin, with a biguanide, which lowers glucose production in the liver and improves insulin ...
  • Hydroxocobalamin + Betamethasone + Diclofenac Sodium

    Product Hydroxocobalamin + Betamethasone + Diclofenac Sodium

    Hydroxocobalamin, Betamethasone, and Diclofenac Sodium is a highly potent therapeutic formulation designed to treat acute, severe musculoskeletal and neurological painful-inflammatory conditions. It works through a synergistic triple mechanism that combines a non-steroidal anti-inflammatory drug (NSAID), a...
show all 99 other products

Swiftmed International Private Limited resources (1)